Cargando…
Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma
SIMPLE SUMMARY: The combination of Resminostat (HDACi) and Ruxolitinib (JAKi) exerted cytotoxic effects and inhibited proliferation of CTCL cell lines (MyLa, SeAx) in vitro. The aim of the present study was to validate their antitumor effects in vivo using the chick embryo chorioallantoic membrane (...
Autores principales: | Karagianni, Fani, Piperi, Christina, Casar, Berta, de la Fuente-Vivas, Dalia, García-Gómez, Rocío, Lampadaki, Kyriaki, Pappa, Vasiliki, Papadavid, Evangelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870185/ https://www.ncbi.nlm.nih.gov/pubmed/35205818 http://dx.doi.org/10.3390/cancers14041070 |
Ejemplares similares
-
Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma
por: Karagianni, Fani, et al.
Publicado: (2021) -
Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports
por: Lampadaki, Kyriaki, et al.
Publicado: (2021) -
Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential
por: Karagianni, Fani, et al.
Publicado: (2022) -
Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions
por: KOUMOURTZIS, Marios, et al.
Publicado: (2022) -
The therapeutic properties of resminostat for hepatocellular carcinoma
por: Zhao, Jun, et al.
Publicado: (2018)